USPTO serial 79260744
NU.Q
Reviewed by CopyMark Law Group
Reg. 6044605Status 706Registered
- Filing date
- Status date
- Registration date
- May 5, 2020
- Examiner
- BHUPATHI, TARA
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with NU.Q?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan Michaels
Megan Michaels Crowell & Moring LLPP.O. Box 10395Chicago, IL 60610United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; chemicals and other chemical preparations used in diagnostics for scientific or research use; chemical reagents for use in industry and science; chemical, biological and diagnostic reagents for scientific or research use, preparations and substances for scientific, diagnostic and research purposes, namely reagent, cells, enzymes; chemical and biological preparations and reagents for use in diagnostic and analytical tests, including in vitro diagnostic laboratory tests; in vitro diagnostics preparations, diagnostic reagents for in vitro laboratory use; reagents for life science scientific purposes | ACTIVE | — |
| 005 | Pharmaceutical and diagnostic products and preparations, namely, pharmaceutical products for the treatment of cancer and cancer diagnostic preparations for medical purposes; medical diagnostic testing materials, namely, test strips for use in the field of cancer, reagents and assays for testing bodily fluids for cancer; diagnostic reagents for medical use; diagnostic reagents, namely, reagents for medicinal use; diagnostic reagents for medical use; medical preparations for detection and diagnosis of cancer; medical preparations for detection and diagnosis of inflammation; stem cell differentiation status test preparations for medical purposes in the field of cancer diagnosis, testing, and treatment; chemical, biological and diagnostic reagents and preparations for medical purposes in the field of cancer diagnosis, testing, and treatment; medical preparations for detection and diagnosis of diseases | ACTIVE | — |
| 010 | Surgical, medical and diagnostic apparatus and instruments, namely, cancer diagnostic apparatus and instruments, medical apparatus for use in cancer surgery; diagnostic measuring apparatus for medical use, namely, diagnostic measuring apparatus for detecting cellular status; medical apparatus, instruments and equipment for use in the detection of cancer; in vitro diagnostic testing apparatus for medical use; in vitro diagnostic testing apparatus incorporating chemical reagents, for medical use; medical apparatus for testing blood; medical apparatus, instruments and equipment for use in the detection of disease; parts and fittings for all the aforesaid | ACTIVE | — |
| 042 | Scientific and technological services, namely scientific testing and analysis in the field of the detection, diagnosis and treatment of cancer; industrial analysis of industrial fluids and industrial research services in the field of the detection, diagnosis and treatment of cancer; research and development, consultancy and advisory services relating to biotechnology, medical technology, medical diagnostic assays, medical diagnostics, medical diagnostic reagents, substances, preparations and materials, detection of cancer and other diseases; analytical testing and diagnostic services, namely providing medical testing services and computer diagnostic services, all in the field of cancer research and disease classification; design and development of medical diagnostic testing apparatus and reagents; blood analysis services; information, advisory, and consultancy services relating to all the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Belgian Volition SPRL
- Other trademarks owned by Belgian Volition SPRL
- Other trademarks owned by Belgian Volition SPRL
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named NU.Q
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 17, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 17, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Aug 10, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 30, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 13, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 5, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 3, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 11, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 11, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 5, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 5, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 14, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 29, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 29, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 16, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 2, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 12, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 12, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 25, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 24, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 18, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 18, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 13, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |